Table 3.
Cancer Type | 1995-1999 | 2000-2004 | ||||
---|---|---|---|---|---|---|
| ||||||
SEP 1c | SEP 5d | SRR (95% CI)e | SEP 1c | SEP 5d | SRR (95% CI)e | |
All sites | 172.0 | 170.4 | 1.00 (0.94-1.07) | 151.4 | 155.6 | 0.97 (0.91-1.03) |
Brain and other nervous system | NCf | NCf | NCf | 1.1 | 2.3 | 0.50 (0.22-1.00) |
Colon and rectum | 11.9 | 17.3 | 0.68 (0.53-0.86) | 13.1 | 18.1 | 0.72 (0.58-0.89) |
Esophagus | 11.5 | 7.7 | 1.50 (1.15-1.94) | 8.0 | 5.9 | 1.37 (1.01-1.83) |
Kidney and renal pelvis | 2.0 | 2.2 | 0.94 (0.49-1.67) | 2.2 | 2.4 | 0.92 (0.51-1.56) |
Larynx | 4.5 | 4.5 | 1.01 (0.66-1.49) | 3.4 | 3.1 | 1.10 (0.69-1.69) |
Leukemia | 5.9 | 5.1 | 1.15 (0.79-1.62) | 5.0 | 5.5 | 0.91 (0.63-1.28) |
Liver and intrahepatic bile duct | 9.4 | 12.0 | 0.78 (0.59-1.01) | 8.6 | 12.4 | 0.69 (0.52-0.89) |
Lung and bronchus | 24.3 | 25.1 | 0.96 (0.81-1.14) | 18.2 | 23.5 | 0.77 (0.64-0.92) |
Non-Hodgkin lymphoma | 4.0 | 5.1 | 0.78 (0.50-1.16) | 4.5 | 5.4 | 0.81 (0.55-1.17) |
Oral cavity and pharynx | 8.1 | 6.7 | 1.21 (0.88-1.62) | 6.0 | 5.5 | 1.10 (0.78-1.52) |
Pancreas | 8.0 | 6.9 | 1.15 (0.84-1.55) | 4.3 | 6.7 | 0.64 (0.43-0.92) |
Penis | NCf | NCf | NCf | NCf | NCf | NCf |
Prostate | 30.5 | 37.7 | 0.80 (0.69-0.93) | 35.1 | 31.1 | 1.12 (0.98-1.29) |
Stomach | 19.0 | 10.5 | 1.80 (1.46-2.22) | 13.1 | 8.2 | 1.59 (1.25-2.00) |
Thyroid | NCf | NCf | NCf | NCf | NCf | NCf |
Urinary bladder | 3.6 | 3.3 | 1.09 (0.67-1.72) | 3.7 | 3.5 | 1.07 (0.68-1.63) |
Abbreviations: SRR, standardized rate ratio; CI, confidence interval; NC, not calculated.
Rates are per 100,000 and are age-adjusted to the Census 2000 population for Puerto Rico (12).
See Methods for calculations used to derive SEP scores.
SEP 1 is the lowest socioeconomic position.
SEP 5 is the highest socioeconomic position and is the reference group.
Defined as SEP 1 divided by SEP 5 according to the Tiwari method.
Cell contains <15 cases in 1 of the categories.